All News

2061 articles, sorted by publication time.

New Drugs and Clinical Research · us

Another Oral Option for Treatment-Refractory Herpes: FDA Approves pritelivir for Immunocompromised Adults

When commonly used antivirals fail to heal herpes lesions, immunocompromised patients often face more difficult treatment challenges. Newly approved pritelivir increased the proportion of patients achieving complete healing within 28 days in a randomized trial, but this advance has a clearly defined scope and does not mean the infection can be eradicated.

Medical Artificial Intelligence · uk

Triaging Low-Risk Skin Lesions First: UK Autonomous AI Pilot Frees Up Dermatology Consultation Time

A 16-month evaluation at two UK hospitals found that around one-quarter to one-third of patients could complete their suspected skin cancer referral pathway following AI assessment. The specialist time saved offers the potential to expand services, but six missed cancers also underscore the need for ongoing follow-up to support autonomous decision-making.

Immunity and Infection · us

Keeping Lung Immunity in a Culture Dish: Human Lung Organoids Reveal Local Antiviral Defenses

Organoids that retain the lung tissue’s original immune cells can mount a specific response to SARS-CoV-2; stimulating them first with viral fragments can also reduce subsequent infection. This provides a new tool for studying lung immunity and vaccine strategies, but the protective effect has so far been demonstrated only in a laboratory model.